...2014 ). Bellicum’s BPX-061 is a chimeric antigen receptor (CAR) T cell therapy targeting prostate stem cell antigen (PSCA... ...recommended extension dose Status: Phase I started Milestone: NA
Bellicum Pharmaceuticals Inc.
Takeda Pharmaceutical Co. Ltd.
Prostate stem cell antigen (PSCA...
...finely tuned signaling," said Sadelain. In proof-of-concept studies, the MSKCC-Dresden group focused on prostate stem cell antigen ( PSCA... ...highly expressed in metastatic prostate cancer, although neither antigen is absolutely specific to prostate tissue. PSCA... ...PSCA + /PSMA - and PSCA - /PSMA + tumors, T cells expressing an attenuated, PSCA-specific...